(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
3 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 12.80%
-0.91% $ 16.36
@ $10.44
Emitido: 13 feb 2024 @ 10:07
Retorno: 56.66%
Señal anterior: feb 12 - 13:04
Señal anterior:
Retorno: -6.09 %
Live Chart Being Loaded With Signals
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States...
Stats | |
---|---|
Volumen de hoy | 10 535.00 |
Volumen promedio | 29 570.00 |
Capitalización de mercado | 96.43M |
EPS | $0 ( 2024-05-02 ) |
Próxima fecha de ganancias | ( $-1.940 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.830 |
ATR14 | $0.145 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-01 | Zung Jonathan B. | Buy | 500 000 | Employee stock option (right to buy) |
2023-05-01 | Zung Jonathan B. | Buy | 0 | |
2023-01-23 | Kaitin Kenneth I | Buy | 85 000 | Non Qualified Stock Option |
2023-01-23 | Hohneker John | Buy | 85 000 | Non Qualified Stock Option |
2023-01-23 | Rubin Marc | Buy | 85 000 | Non Qualified Stock Option |
INSIDER POWER |
---|
86.47 |
Last 97 transactions |
Buy: 14 857 117 | Sell: 1 304 959 |
Curis Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
BUR | 0.887 |
ARCT | 0.884 |
PSTV | 0.882 |
IFRX | 0.882 |
FTRI | 0.881 |
EZFL | 0.878 |
CWBC | 0.876 |
VTSI | 0.866 |
SBET | 0.864 |
MDRR | 0.861 |
10 Correlaciones Más Negativas | |
---|---|
AMRB | -0.912 |
PKOH | -0.886 |
SMH | -0.881 |
SNCY | -0.873 |
AMRS | -0.856 |
CHB | -0.852 |
GPRE | -0.85 |
VOXX | -0.846 |
FLDM | -0.844 |
VTRU | -0.833 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Curis Inc Finanzas
Annual | 2023 |
Ingresos: | $10.02M |
Beneficio Bruto: | $9.81M (97.88 %) |
EPS: | $-8.96 |
FY | 2023 |
Ingresos: | $10.02M |
Beneficio Bruto: | $9.81M (97.88 %) |
EPS: | $-8.96 |
FY | 2022 |
Ingresos: | $10.16M |
Beneficio Bruto: | $9.91M (97.47 %) |
EPS: | $-12.92 |
FY | 2021 |
Ingresos: | $10.65M |
Beneficio Bruto: | $10.12M (94.99 %) |
EPS: | $-0.500 |
Financial Reports:
No articles found.
Curis Inc
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico